Page last updated: 2024-09-02

fingolimod hydrochloride and atenolol

fingolimod hydrochloride has been researched along with atenolol in 1 studies

Compound Research Comparison

Studies
(fingolimod hydrochloride)
Trials
(fingolimod hydrochloride)
Recent Studies (post-2010)
(fingolimod hydrochloride)
Studies
(atenolol)
Trials
(atenolol)
Recent Studies (post-2010) (atenolol)
2,7711572,0625,4731,950852

Protein Interaction Comparison

ProteinTaxonomyfingolimod hydrochloride (IC50)atenolol (IC50)
Beta-1 adrenergic receptorHomo sapiens (human)0.7468
Alpha-1D adrenergic receptorHomo sapiens (human)0.23
Alpha-1A adrenergic receptorHomo sapiens (human)0.23
Alpha-1B adrenergic receptorHomo sapiens (human)0.23

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbet, I; Goldwater, DR; Kovarik, JM; Lu, M; Maton, S; Riviere, GJ; Schmouder, RL1

Trials

1 trial(s) available for fingolimod hydrochloride and atenolol

ArticleYear
The effect on heart rate of combining single-dose fingolimod with steady-state atenolol or diltiazem in healthy subjects.
    European journal of clinical pharmacology, 2008, Volume: 64, Issue:5

    Topics: Adolescent; Adult; Antihypertensive Agents; Area Under Curve; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Diltiazem; Female; Fingolimod Hydrochloride; Heart Rate; Humans; Immunosuppressive Agents; Male; Middle Aged; Propylene Glycols; Receptors, Lysosphingolipid; Single-Blind Method; Sphingosine

2008